Methimazole protects lungs during hepatic ischemia-reperfusion injury in rats: an effect not induced by

Tanju Tütüncü1, Cagatay Demirci, Ugur Gözalan

  • 1Fourth Department of Surgery, Ankara Numune Education and Research Hospital, Sihhiye, Turkey.

Abstract

Insights

Methimazole protects lungs from hepatic ischemia-reperfusion injury by reducing inflammation and oxidative stress. This study shows methimazole’s benefits extend beyond its effects on thyroid hormones.

Area of Science:

  • Medical research
  • Toxicology
  • Organ injury

Background:

  • Hepatic ischemia-reperfusion injury (HIRI) can cause remote organ damage, notably respiratory dysfunction.
  • Understanding protective mechanisms against HIRI-induced lung injury is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the potential protective effects of methimazole on lung tissue following HIRI.
  • To differentiate the effects of methimazole from hypothyroidism-induced changes.

Main Methods:

  • Male Wistar rats underwent HIRI and pulmonary lobectomy, with interventions including thyroidectomy, methimazole, and L-thyroxine administration.
  • Pulmonary tissue was analyzed histopathologically and biochemically for myeloperoxidase and malondialdehyde levels.

Main Results:

  • All HIRI groups exhibited increased pulmonary injury indices compared to controls.
  • Methimazole administration significantly reduced pulmonary injury and biochemical markers of damage compared to the HIRI-only group.
  • Pulmonary damage in the HIRI group was comparable to the thyroidectomized group, suggesting effects beyond hypothyroidism.

Conclusions:

  • Methimazole demonstrates a protective effect on lung tissue during HIRI.
  • These protective effects are likely due to methimazole's anti-inflammatory and antioxidant properties.
  • The benefits of methimazole are not solely attributable to the induction of hypothyroidism.

Related Concept Videos